Publicaciones en las que colabora con ALICIA ARRANZ ROMERA (8)

2021

  1. A safe gdnf and gdnf/bdnf controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: Potential usefulness in degenerative retinal pathologies

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-24

  2. Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 566-580

2019

  1. Co-liberación de agentes neuroprotectores a partir de sistemas microparticulares biodegradables: uso potencial en el tratamiento de patologías degenerativas del nervio óptico y de la retina

    Co-liberación de agentes neuroprotectores a partir de sistemas microparticulares biodegradables: uso potencial en el tratamiento de patologías degenerativas del nervio óptico y de la retina

  2. Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases

    Drug Discovery Today, Vol. 24, Núm. 8, pp. 1644-1653

  3. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma

    Journal of Controlled Release, Vol. 297, pp. 26-38

2018

  1. Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina

    Advanced Drug Delivery Reviews, Vol. 126, pp. 127-144

  2. Photoreceptor preservation induced by intravitreal controlled delivery of gdnf and gdnf/melatonin in rhodopsin knockout mice

    Molecular Vision, Vol. 24, pp. 733-745

2017

  1. Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration

    PLoS ONE, Vol. 12, Núm. 5